SAN FRANCISCO--(BUSINESS WIRE)--Girard Gibbs LLP is investigating claims on behalf of investors of Rockwell Medical, Inc. (NASDAQ: RMTI) involving possible securities law violations.
To speak privately with an attorney regarding this class action lawsuit investigation, click here.
After the close of trading on May 22, 2018, Rockwell Medical, Inc. (NASDAQ:RMTI) announced that the Company’s President and Chief Executive Officer, Robert Chioini, “has been terminated from his positions, effective immediately.”
Following this press release, Chioini signed a report filed on Form 8-K with the U.S. Securities and Exchange Commission, disclosing that:
“A board meeting called for the purpose of discussing a shareholder demand letter and informing the board that the independent non-conflicted directors had hired independent counsel to conduct an internal investigation in response to the demand letter requiring immediate initiation of an investigation of alleged breach of fiduciary duties by various directors and other possible violations of federal securities laws. The directors who are the subjects of the allegations of breaches of fiduciary duty asserted the position that they voted to fire the CEO.”
In the wake of this news, trading in Rockwell shares halted trading on May 23 and May 24, 2018.
If you purchased or acquired RMTI and would like to speak privately with a securities attorney to learn more about the investigation or your legal rights as an investor, please visit our website or contact the securities team directly at (800) 254-9493.
About Girard Gibbs
Girard Gibbs is a national litigation firm representing investors, businesses, municipalities and unions in class and individual actions in state and federal courts throughout the country. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have been honored for the quality of their work and legal achievements with recognition in the Best Lawyers in America list for five consecutive years.
This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
